Skip to main content
. Author manuscript; available in PMC: 2024 Jul 17.
Published in final edited form as: Clin Cancer Res. 2024 Jan 17;30(2):379–388. doi: 10.1158/1078-0432.CCR-23-1889

Figure 4. Association of p-ERK with survival in glioblastoma patients treated with immune checkpoint blockade.

Figure 4.

a, OS comparison between high and low p-ERK groups in the complete glioblastoma patient cohort. b, OS comparison between high and low p-ERK groups in wild-type IDH glioblastoma patients. c, Overall survival comparison among high, medium, and low p-ERK groups in the exploratory analysis.